255 related articles for article (PubMed ID: 32738771)
1. Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis.
Zhao D; Hajiaghamohseni LM; Liu X; Szulc ZM; Bai A; Bielawska A; Norris JS; Reddy SV; Hannun YA; Haque A
Cytokine; 2020 Nov; 135():155219. PubMed ID: 32738771
[TBL] [Abstract][Full Text] [Related]
2. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.
Goldstein OG; Hajiaghamohseni LM; Amria S; Sundaram K; Reddy SV; Haque A
Cancer Immunol Immunother; 2008 Oct; 57(10):1461-70. PubMed ID: 18343923
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitor.
Podolin PL; Bolognese BJ; Carpenter DC; Davis TG; Johanson RA; Fox JH; Long E; Dong X; Marquis RW; Locastro SM; Terfloth GJ; Kurali E; Peterson JJ; Smith BR; McQueney MS; Yamashita DS; Capper-Spudich EA
J Immunol; 2008 Jun; 180(12):7989-8003. PubMed ID: 18523262
[TBL] [Abstract][Full Text] [Related]
4. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
5. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis.
Turley DM; Miller SD
J Immunol; 2007 Feb; 178(4):2212-20. PubMed ID: 17277126
[TBL] [Abstract][Full Text] [Related]
6. NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing.
Allan ER; Tailor P; Balce DR; Pirzadeh P; McKenna NT; Renaux B; Warren AL; Jirik FR; Yates RM
J Immunol; 2014 Jun; 192(11):4989-5001. PubMed ID: 24778444
[TBL] [Abstract][Full Text] [Related]
7. HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition.
Amria S; Hajiaghamohseni LM; Harbeson C; Zhao D; Goldstein O; Blum JS; Haque A
Eur J Immunol; 2008 Jul; 38(7):1961-70. PubMed ID: 18506881
[TBL] [Abstract][Full Text] [Related]
8. T cell selection and differential activation on structurally related HLA-DR4 ligands.
Gebe JA; Novak EJ; Kwok WW; Farr AG; Nepom GT; Buckner JH
J Immunol; 2001 Sep; 167(6):3250-6. PubMed ID: 11544312
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells.
Costantino CM; Ploegh HL; Hafler DA
J Immunol; 2009 Jul; 183(2):945-52. PubMed ID: 19553543
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cells recognizing a single self-peptide expressed by APCs induce spontaneous autoimmune arthritis.
Rankin AL; Reed AJ; Oh S; Cozzo Picca C; Guay HM; Larkin J; Panarey L; Aitken MK; Koeberlein B; Lipsky PE; Tomaszewski JE; Naji A; Caton AJ
J Immunol; 2008 Jan; 180(2):833-41. PubMed ID: 18178822
[TBL] [Abstract][Full Text] [Related]
11. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
12. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.
Shi GP; Bryant RA; Riese R; Verhelst S; Driessen C; Li Z; Bromme D; Ploegh HL; Chapman HA
J Exp Med; 2000 Apr; 191(7):1177-86. PubMed ID: 10748235
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: Conditional MHC class II expression reveals a limited role for B cell antigen presentation in primary and secondary CD4 T cell responses.
Archambault AS; Carrero JA; Barnett LG; McGee NG; Sim J; Wright JO; Raabe T; Chen P; Ding H; Allenspach EJ; Dragatsis I; Laufer TM; Wu GF
J Immunol; 2013 Jul; 191(2):545-50. PubMed ID: 23772037
[TBL] [Abstract][Full Text] [Related]
14. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
[TBL] [Abstract][Full Text] [Related]
17. Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases.
Yau AC; Piehl F; Olsson T; Holmdahl R
Immunology; 2017 Apr; 150(4):408-417. PubMed ID: 27861821
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
19. Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing.
Hastings KT; Lackman RL; Cresswell P
J Immunol; 2006 Dec; 177(12):8569-77. PubMed ID: 17142755
[TBL] [Abstract][Full Text] [Related]
20. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
Li Y; Ke Y; Gottlieb PD; Kapp JA
J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]